Steven Charles Loechel

This inventor holds 7 USPTO granted patents and 1 published patent application and 6 EPO patents. Top assignee: Neurosearch A/s. Active years: 2010-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven Charles Loechel. Retrieved from https://idiyas.com/inventor/steven-charles-loechel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 1)

% Patents Active = 14.3

EPO Patents = 6 (Patent Applications = 3)

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 13(Granted Patents)

Company Filing History:

7 out of 206

Neurosearch A/s

patents

Years Active: 2010-2013

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8372832 - 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use (2013-02-12),

2. 8158619 - 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use (2012-04-17),

3. 8148365 - 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use (2012-04-03),

4. 8101598 - 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use (2012-01-24),

5. 7915272 - 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use (2011-03-29),

6. 7910578 - 8,10-diaza-bicyclo[4.3.1]decane derivatives and their medical use (2011-03-22),

7. 7807667 - 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use (2010-10-05),

Title: The Innovations of Steven Charles Loechel

Introduction

Steven Charles Loechel is a notable inventor based in Frederiksberg, Denmark. He has made significant contributions to the field of pharmaceuticals, holding a total of seven patents. His work focuses on novel compounds that have potential medical applications.

Latest Patents

One of Loechel's latest patents involves 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use. This invention relates to novel derivatives that are utilized in the manufacture of pharmaceutical compositions. The compounds are identified as cholinergic ligands at the nicotinic acetylcholine receptors and modulators of monoamine receptors and transporters. Due to their pharmacological profile, these compounds may be beneficial in treating a variety of diseases or disorders. These include conditions related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), smooth muscle contraction, endocrine disorders, neuro-degeneration, inflammation, pain, and withdrawal symptoms from chemical substance abuse.

Career Highlights

Loechel is currently associated with Neurosearch A/S, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the understanding and treatment of various medical conditions through his patented compounds.

Collaborations

He has collaborated with notable colleagues such as Dan Peters and Gunnar M. Olsen, contributing to a dynamic research environment that fosters innovation.

Conclusion

Steven Charles Loechel's contributions to the field of pharmaceuticals through his patents highlight his role as a significant inventor. His work not only advances medical science but also offers hope for the treatment of various disorders.

Profile summary based on public USPTO records.